1,25-dihydroxyergocalciferol has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grygorowicz, MA; Kotlarz, A; Kutner, A; Markowicz, S; MiĆoszewska, J; Przybyszewska, M; Swoboda, P | 1 |
1 other study(ies) available for 1,25-dihydroxyergocalciferol and Angiogenesis, Pathologic
Article | Year |
---|---|
Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
Topics: Antimetabolites, Antineoplastic; Calcitriol; Cell Self Renewal; Cell Survival; Colonic Neoplasms; Dihydroxycholecalciferols; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Ergocalciferols; Fluorouracil; Gene Expression; HCT116 Cells; HT29 Cells; Humans; Neoplastic Stem Cells; Neovascularization, Pathologic | 2016 |